Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Use of anti-carbapenem-resistant Enterobacterales (anti-CRE) agents such as ceftazidime/avibactam has been associated with improved clinical outcome in cohorts that primarily include patients infected with CRE that are resistant to meropenem (MCRE). To clarify whether patients with CRE resistant to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of antimicrobial chemotherapy 2024-08, Vol.79 (8), p.1929-1937
Hauptverfasser:	Weston, Gregory, Giri, Abhigya, Komarow, Lauren, Ge, Lizhao, Baum, Keri R, Abbenante, Erin, Gallagher, Jason C, Jacob, Jesse T, Kaye, Keith S, Kim, Angela C, Huskins, W Charles, Zervos, Marcus, Herc, Erica, Patel, Robin, Van Duin, David, Doi, Yohei
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!